At Sonoma, we believe that the strength and success of our company is only possible by fostering a work environment where everyone feels confident to express themselves freely and authentically.? This #GlobalDiversityAwarenessMonth, and year-round, we are committed to diversity, equity and ensuring that individuals feel valued for their unique contributions. #OneSonoma Learn more about our values: https://bit.ly/4e7YAxk
Sonoma Biotherapeutics
生物技术研究
South San Francisco，California 14,427 位关注者
Leading the Next Frontier of Cell Therapy
关于我们
Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted Treg cell therapies designed to induce durable immune tolerance to treat and prevent autoimmune and inflammatory diseases. Sonoma Biotherapeutics is based in South San Francisco and Seattle.
- 网站
-
https://www.sonomabio.com
Sonoma Biotherapeutics的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- South San Francisco，California
- 类型
- 私人持股
- 领域
- cell therapy和autoimmune disease
地点
Sonoma Biotherapeutics员工
动态
-
We are excited to have Mei-Lun Wang, MD join the Sonoma team as SVP of Clinical Development. Dr. Wang’s passion for developing novel therapies and her expertise in immunology and gastroenterology will make her an impactful leader here at Sonoma. Welcome, Mei-Lun Wang, MD!
-
-
This morning, Sonoma CEO & President Jeffrey Bluestone participated on a panel discussing the advancement of cell therapies for autoimmune disease at the Goldman Sachs Research Cell Therapy Day in New York City. Learn more about Sonoma’s approach to treating these diseases: https://bit.ly/3TNmN3J
-
-
Tomorrow, Sonoma CEO & President Jeffrey Bluestone and CFO Jessica Stitt will attend the Bank of America Healthcare Trailblazers Private Company Conference in Boston, where Jeff will discuss the role of cell therapies in autoimmune disease during a panel discussion at the World Innovation Medical Forum. Learn more about the forum: https://bit.ly/47EfCkf
-
-
Our?CEO?Jeffrey Bluestone, recently sat down for a conversation with The Cura Foundation, to explore the intricacies of the immune system and?advancements in #immunology that have paved the way for Sonoma Bio's work to develop #Treg therapies with the potential to induce #immunetolerance and treat #autoimmune diseases Read the full interview here: https://lnkd.in/du9Dnggf.
-
At Sonoma Bio, we believe in the power of community and the importance of giving back. During #SonomaServiceTime, members of our team volunteered at meaningful local community organizations, dedicating their time and efforts to support and uplift others. #OneSonoma
-
We’ve received a $45 million milestone payment from Regeneron as part of our ongoing collaboration to discover, develop and commercialize engineered #Treg therapies for #autoimmune diseases. Learn more about our partnership here: https://lnkd.in/g8M3Dt6w.
-
Earlier this month, some of our colleagues joined Samaritan House of San Mateo County’s annual Backpack Drive to distribute much needed supplies to help children feel confident going back to school. Thanks to our employees for their willingness to give back to our local community! #OneSonoma?
-
We recently gathered for our annual summer picnic events! Our #SSF team braved the rain while exploring the San Francisco Zoo & Gardens and our #SEA team visited the Museum of Pop Culture (MoPOP) while enjoying a sunny day in Seattle. #OneSonoma
-
#ICYMI: Our Chief Scientific Officer, Joe Arron, sat down with Nature Portfolio's Charlotte Harrison to discuss our work engineering regulatory T cells (#Tregs) to restore immune balance and treat #autoimmune disorders. Discover how the broader #biotech field is working to transform the treatment paradigm for autoimmune disease here: https://lnkd.in/eQ9UKbSd. #Treg
-